What is NDC 68180-709?

68180-709 is the product NDC for Rivaroxaban, Rivaroxaban 2.5 mg/1 tablet, film coated, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivaroxaban?

32 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivaroxaban NDC 68180-709 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-709Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0709Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68180-709-06	6818007090668180070906	30 TABLET, FILM COATED in 1 BOTTLE (68180-709-06)Marketed from Mar 6, 2025
68180-709-09	6818007090968180070909	90 TABLET, FILM COATED in 1 BOTTLE (68180-709-09)Marketed from Mar 6, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivaroxaban
Generic name (nonproprietary): rivaroxaban
Active ingredients: Rivaroxaban — 2.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.NDC labeler code 68180
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208555
Marketing start: Mar 6, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Factor Xa Inhibitors (Mechanism)
Identifiers: Product ID 68180-709_310f0bf6-9b0f-441b-afd7-b9a0f7905395SPL ID 310f0bf6-9b0f-441b-afd7-b9a0f7905395SPL set ID 702fed3e-ae25-49ba-98cc-562e0e244214RxCUI 2059015UNII 9NDF7JZ4M3UPC 0368180709060
Pharmacologic class: Factor Xa Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468180070906 followed by a unit qualifier and the quantity

Package 68180-0709-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 8, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Rivaroxaban is a factor Xa inhibitor indicated: to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) ( 1.7 ) to reduce the risk of major thrombotic vascular events in patients with peripheral artery disease (PAD), including patients after recent lower extremity revascularization due to symptomatic PAD ( 1.8 ) 1.7 Reduction of Risk of Major Cardiovascular Events in Patients with Coronary Artery Disease (CAD) Rivaroxaban tablets, in combination with aspirin, are indicated to reduce the risk of major cardiovascular events (cardiovascular death, myocardial infarction, and stroke) in adult patients with coronary artery disease. 1.8 Reduction of Risk of …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68180-709

What is NDC 68180-709?: 68180-709 is the product NDC for Rivaroxaban, Rivaroxaban 2.5 mg/1 tablet, film coated, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivaroxaban.
What is the active ingredient?: Rivaroxaban.
Who is the labeler?: Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivaroxaban?: 32 other product NDCs are listed under this name. See all Rivaroxaban NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivaroxaban NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Lifestar Pharma LLC	70756-006	70756-0006-1270756-0006-6070756-0006-81+1 more
Rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Micro Labs Limited	42571-345	42571-0345-0542571-0345-3042571-0345-60
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-890	72603-0890-0172603-0890-02
rivaroxaban	Rivaroxaban 10 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0540	55488-0540-01
rivaroxaban	Rivaroxaban 15 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0541	55488-0541-01
rivaroxaban	Rivaroxaban 20 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0542	55488-0542-01
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	XLCare Pharmaceuticals, Inc.	72865-321	72865-0321-1872865-0321-60
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-416	72205-0416-0272205-0416-0372205-0416-04+1 more
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, CoatedOral	Sun Pharmaceutical Industries, Inc.	51672-4228	51672-4228-0451672-4228-09
rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-405	71921-0405-0671921-0405-21

All 33 Rivaroxaban NDCs